Response rates and recurrence patterns after low-dose radiotherapy with 4 Gy in patients with low-grade lymphomas.

Laila KönigJuliane Hörner-RieberDenise BernhardtAdriane HommertgenStefan RiekenJürgen DebusKlaus Herfarth

Published in: Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] (2018)

Primary LDRT is an effective treatment with high ORR and long-lasting remissions in a subset of patients with low-grade lymphoma, and may therefore be a curative treatment option for patients with low tumor burden. LDRT with the CD20 antibody obinutuzumab will soon be tested in a prospective multicenter trial.

Keyphrases

low grade
high grade
low dose
clinical trial
early stage
diffuse large b cell lymphoma
squamous cell carcinoma
study protocol
radiation therapy
locally advanced
rectal cancer